Stock listing

NSE:WOCKPHARMA Wockhardt Limited Share Price

Home listing (NSE) of Wockhardt Limited

Follow Wockhardt Limited into a list and get an email when it puts out news.

Share price · NSE:WOCKPHARMA

₹2,184.40 INR +157.80 (+7.8%)

Close on Nov 20, 2026

Past year +64.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₹2,145.00 – ₹2,214.50 INRNov 20, 2026
Volume
923,229 sharesNov 20, 2026
Market cap
₹354.9B INRAt the close on Nov 20, 2026 · price × 162.5M shares outstanding
52-week range
₹1,086.70 – ₹2,422.30 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₹1.81B INRMedian day 688,530 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Wockhardt Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NSE:WOCKPHARMA · Home₹2,184.40 INR+157.80 (+7.8%)923,229₹2,160.00₹2,214.50₹2,145.00₹2,026.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:WOCKPHARMA · INR, adjusted for splits

DayCloseChange%OpenHighLowVolume
₹2,184.40+157.80+7.8%₹2,160.00₹2,214.50₹2,145.00923,229
₹2,026.60+17.70+0.9%₹2,018.30₹2,065.00₹2,005.00725,564
₹2,008.90+4.40+0.2%₹2,004.50₹2,049.70₹1,992.00319,674
₹2,004.50-22.70-1.1%₹2,027.20₹2,059.60₹1,983.40560,334
₹2,027.20-26.80-1.3%₹2,050.00₹2,075.50₹2,012.00392,491
₹2,054.00+19.40+1.0%₹2,034.60₹2,064.00₹2,025.00342,566
₹2,034.60+3.10+0.2%₹2,058.00₹2,070.50₹2,015.10436,046
₹2,031.50+84.50+4.3%₹1,992.10₹2,089.00₹1,976.60896,543
₹1,947.00-42.70-2.1%₹1,982.00₹1,984.60₹1,903.10668,237
₹1,989.70+90.70+4.8%₹1,935.00₹2,032.00₹1,897.001,639,386
₹1,899.00+31.00+1.7%₹1,875.00₹1,913.70₹1,858.20448,001
₹1,868.00-28.50-1.5%₹1,851.00₹1,915.00₹1,804.201,162,132
₹1,896.50-4.60-0.2%₹1,903.10₹1,915.00₹1,864.10606,501
₹1,901.10-21.80-1.1%₹1,923.00₹1,932.90₹1,872.00506,614
₹1,922.90+9.50+0.5%₹1,906.00₹1,960.50₹1,886.40496,447
₹1,913.40+28.60+1.5%₹1,885.00₹1,934.00₹1,861.20490,595
₹1,884.80+75.20+4.2%₹1,814.80₹1,893.00₹1,805.00524,201
₹1,809.60+7.90+0.4%₹1,795.00₹1,834.00₹1,780.50798,498
₹1,801.70-53.80-2.9%₹1,857.00₹1,864.00₹1,772.00879,063
₹1,855.50-21.70-1.2%₹1,872.00₹1,899.90₹1,846.00457,019
₹1,877.20-29.10-1.5%₹1,920.90₹1,926.00₹1,858.00471,545
₹1,906.30-48.60-2.5%₹1,963.70₹1,966.00₹1,900.60360,528
₹1,954.90+5.50+0.3%₹1,957.00₹1,985.50₹1,941.10448,312
₹1,949.40-36.70-1.8%₹1,988.00₹1,988.00₹1,931.20410,296
₹1,986.10+3.00+0.2%₹1,986.00₹2,003.90₹1,960.40483,873
₹1,983.10+19.90+1.0%₹1,970.00₹2,000.20₹1,901.001,001,334
₹1,963.20-33.20-1.7%₹2,002.90₹2,025.10₹1,945.60881,944
₹1,996.40-33.20-1.6%₹2,045.80₹2,064.00₹1,986.10687,125
₹2,029.60-120.80-5.6%₹2,150.40₹2,159.80₹2,019.00769,434
₹2,150.40-26.00-1.2%₹2,175.00₹2,197.00₹2,130.40463,533
₹2,176.40+112.90+5.5%₹2,067.20₹2,184.00₹2,062.00899,270
₹2,063.50-20.40-1.0%₹2,083.90₹2,093.90₹2,003.00803,153
₹2,083.900.000.0%₹2,083.90₹2,083.90₹2,083.900
₹2,083.90-32.40-1.5%₹2,110.00₹2,124.00₹2,035.60784,540
₹2,116.30-77.90-3.6%₹2,201.10₹2,213.60₹2,106.20823,461
₹2,194.20+6.60+0.3%₹2,199.00₹2,255.00₹2,148.001,274,737
₹2,187.60-78.00-3.4%₹2,267.00₹2,267.00₹2,181.00649,952
₹2,265.60-22.10-1.0%₹2,290.00₹2,329.90₹2,243.00689,934
₹2,287.70-42.00-1.8%₹2,310.00₹2,334.50₹2,265.00824,745
₹2,329.70+144.30+6.6%₹2,199.00₹2,360.00₹2,182.103,834,525
₹2,185.40-1.90-0.1%₹2,205.90₹2,247.00₹2,176.801,006,397
₹2,187.30+101.20+4.9%₹2,096.00₹2,225.00₹2,090.001,771,282
₹2,086.10+13.80+0.7%₹2,072.30₹2,109.30₹2,047.30557,349
₹2,072.30+50.80+2.5%₹2,025.00₹2,090.10₹2,021.50603,193
₹2,021.50-42.60-2.1%₹2,050.00₹2,075.00₹1,967.301,262,973
₹2,064.10-115.30-5.3%₹2,190.00₹2,193.80₹2,055.00851,928
₹2,179.400.000.0%₹2,179.40₹2,179.40₹2,179.400
₹2,179.40-41.20-1.9%₹2,200.00₹2,237.00₹2,167.301,109,909
₹2,220.60-28.20-1.3%₹2,250.00₹2,267.00₹2,197.00693,525
₹2,248.80+24.80+1.1%₹2,225.00₹2,272.90₹2,196.001,394,874
₹2,224.00+16.00+0.7%₹2,200.00₹2,240.00₹2,166.001,343,981
₹2,208.00+119.30+5.7%₹2,112.50₹2,236.00₹2,076.204,319,658
₹2,088.70+138.10+7.1%₹1,980.00₹2,108.50₹1,976.103,557,646
₹1,950.60+46.30+2.4%₹1,904.60₹1,982.00₹1,891.401,056,401
₹1,904.30+53.70+2.9%₹1,846.20₹1,911.00₹1,838.00684,958
₹1,850.60-33.10-1.8%₹1,883.70₹1,887.80₹1,833.30507,087
₹1,883.70-93.40-4.7%₹1,974.90₹1,977.10₹1,872.00852,543
₹1,977.10+15.10+0.8%₹1,976.10₹2,045.00₹1,963.101,581,060
₹1,962.00+79.90+4.2%₹1,883.10₹1,987.00₹1,874.001,210,241
₹1,882.10-17.50-0.9%₹1,890.00₹1,932.30₹1,873.60310,259
₹1,899.60-1.40-0.1%₹1,895.10₹1,914.20₹1,869.60241,579
₹1,901.00+14.70+0.8%₹1,888.00₹1,909.20₹1,867.70306,988
₹1,886.30+55.70+3.0%₹1,831.10₹1,898.80₹1,830.00559,221
₹1,830.60+4.60+0.3%₹1,844.00₹1,852.40₹1,825.00258,015

Splits

1 split · NSE:WOCKPHARMA · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
Ticker
NSE:WOCKPHARMA
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NSE
Currency
INR

What changed lately

Latest news

All Wockhardt Limited news

Wockhardt Limited on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
15 in the last 12 months · 75 in all · newest Nov 2, 2026 · oldest 2012
Decks
22 decks · latest Jun 4, 2026

Where Wockhardt Limited is listed

ListingExchangeCountryCurrency
NSE:WOCKPHARMA · Home listing · This pageNSEIndiaINR
BSE:WOCKPHARMABSEIndiaINR

Valuation

P/E 86.6× against a median of 17.3×: the highest of 9 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
₹370.5B INR
P/E
86.6×
EV/sales
9.9×
EV/EBITDA
51.4×
Price/book
6.9×
Gross margin
45.4%
Operating margin
13.1%
Net margin
10.9%
Debt to equity
0.4×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Wockhardt Limited · NSE:WOCKPHARMAUS$3.83BUS$4.00B86.6×9.9×51.4×6.9×10.9%0.4×n/a
Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A · SZSE:002294US$4.31BUS$4.16Bn/an/an/a3.3×n/a0.1×n/a
3SBio, Inc. · HKEX:1530US$4.02BUS$1.58B3.1×0.6×0.9×1.0×47.9%0.1×n/a
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A · SZSE:002603US$3.73BUS$3.35B18.0×2.8×n/a2.2×17.4%0.0×n/a
Organon & Co. · NYSE:OGNUS$3.65BUS$10.75B17.1×1.8×n/a3.1×3.5%7.2×0.52
Tarsus Pharmaceuticals, Inc. · NASDAQ:TARSUS$3.60BUS$3.36Bn/a4.9×n/a34.6×−102.9%0.7×0.62
Laboratorios Farmaceuticos Rovi, S.A. · BME:ROVIUS$3.54BUS$3.52B17.4×4.2×15.8×4.6×23.9%0.1×n/a
China Resources Pharmaceutical Group Ltd. · HKEX:3320US$3.51BUS$14.04B5.2×0.3×5.1×0.4×1.5%1.9×n/a
Zhejiang Huahai Pharmaceutical Co., Ltd. Class A · SSE:600521US$3.50BUS$3.65B24.6×2.5×n/a2.3×9.8%0.3×n/a
Orion Oyj Class A · OMXHEX:ORNAVUS$3.42BUS$3.40B4.7×1.4×3.5×2.2×30.3%0.1×n/a
Jiangsu Nhwa Pharmaceutical Co., Ltd. Class A · SZSE:002262US$3.42BUS$2.79B20.8×3.0×n/a2.6×17.7%0.0×n/a
Median of the othersUS$3.57BUS$3.46B17.3×2.5×4.3×2.5×17.4%0.1×0.57

Team and board

Officers

OfficerRole
Deepak R. MadnaniChief Financial Officer – Finance
Gopalakrishnan VenkatesanPresident & VP Business Development – Morton Grove Pharmaceuticals & Wockhardt USA LLC
Debolina PartapSr. Vice President – Legal
Om NarayanSenior Vice President – Biotech R&D
Ajay SahniManaging Director – Wockhardt Bio AG; Managing Director – Pinewood Healthcare
Annapurna DasPresident – India Business & NCE Emerging Markets
HUZAIFA KHORAKIWALAExecutive Director
Mahesh V. PatelChief Scientific Officer – New Drug Discovery
MURTAZA KHORAKIWALAManaging Director
Ravi LimayeManaging Director – Wockhardt UK
Sumit GargChief Digital & Information Officer (CDIO)

Board

DirectorRole
HABIL KHORAKIWALAFounder Chairman
AKHILESH GUPTAIndependent Director
Amb. AHMAD JAVEDIndependent Director
AMELIA FERNANDESIndependent Director
HUZAIFA KHORAKIWALAExecutive Director
OM PRAKASH BHATTIndependent Director
VINESH KUMAR JAIRATHIndependent Director
ZAHABIYA KHORAKIWALANon-Executive Director

Decks

DeckKindSlidesDate
Investor Presentation (June 2026)Investor deck36 slidesJun 4, 2026
Investor Presentation (June 2025)Investor deck34 slidesJun 5, 2025
Investor Presentation (October 2024)Investor deck44 slidesOct 21, 2024
Investor Presentation (October 2024)Investor deck43 slidesOctober 2024
Investor Presentation (February 2024)Investor deck29 slidesFeb 26, 2024
Investor Presentation (February 2024)Investor deck28 slidesFebruary 2024
ESG Presentation (August 2023)Sustainability9 slidesAug 1, 2023
ESG Presentation (July 2023)Sustainability8 slidesJuly 2023
Investor Presentation (February 2023)Investor deck35 slidesFeb 21, 2023
Investor Presentation (February 2023)Investor deck34 slidesFebruary 2023
All 22 decks
DeckKindSlidesDate
Investor Presentation (March 2022)Investor deck18 slidesMar 8, 2022
Q1 FY2016 Earnings PresentationEarnings17 slidesAugust 2015
Q4 FY2015 Earnings PresentationEarnings21 slidesMay 2015
Q3 FY2014 Earnings PresentationEarnings23 slidesFebruary 2014
Investor Presentation (October 2013)Investor deck33 slidesOctober 2013
Investor Presentation (August 2013)Investor deck21 slidesAugust 2013
Investor Presentation (May 2013)Investor deck26 slidesMay 2013
Investor Presentation (February 2013)Investor deck33 slidesFebruary 2013
Investor Presentation (November 2012)Investor deck49 slidesNovember 2012
Investor Presentation (February 2007)Investor deck33 slidesFebruary 2007
Investor Presentation (July 2006)Investor deck29 slidesJuly 2006
Q2 2005 Earnings PresentationEarnings35 slidesJul 19, 2005

Open Decks

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue33.7B30.4B28.3B26.6B32.3B27.1B28.4B35.7B39.2B39.7B
Cost of revenue20.8B12.1B12.3B11.7B13.5B12.1B12.7B17.2B18.5B16.9B
Gross profit12.9B18.3B16.0B14.8B18.8B15.0B15.8B18.5B20.7B22.7B
Research and development1.20B1.19B1.32B1.41B1.43B1.72B2.08B2.91B2.87B3.97B
Selling, general and administrative2.75B1.17B1.05B1.10B1.48B1.35B1.02B2.23B2.69B3.03B
Operating income4.03B10.5B8.36B7.06B9.87B5.33B5.99B6.64B7.54B8.23B
Depreciation and amortization2.27B2.17B2.23B2.51B2.47B2.46B2.26B1.66B1.50B1.49B
EBITDA6.30B12.7B10.6B9.57B12.3B7.79B8.24B8.30B9.03B9.72B
Interest expense2.13B2.54B3.05B3.02B2.99B2.49B2.75B2.64B2.50B2.22B
Income before tax2.38B-160.0M-4.20B-6.24B-4.11B-5.68B-3.42B-4.47B-6.41B-2.47B
Income tax390.0M410.0M520.0M-30.0M-1.32B-2.72B-2.04B-1.35B257.0M-211.1M
Net income2.13B-470.0M-4.63B-5.59B-2.44B6.86B-692.2M-1.95B-6.08B-1.96B
Earnings per share, basic13.10-3.00-32.10-38.80-20.2457.10-6.25-17.58-55.01-17.71

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents2.50B1.91B5.05B900.0M3.70B2.32B2.19B3.97B8.97B9.64B
Short-term investments4.12B4.22B160.0M600.0M90.0M54.4M457.3M457.7M4.00B11.5B
Receivables5.88B6.61B6.18B7.97B9.68B9.18B12.5B13.0B9.71B10.6B
Inventory8.87B7.25B6.42B6.58B7.69B7.99B6.90B8.19B8.56B11.1B
Current assets26.1B24.6B21.8B22.1B25.9B24.2B24.3B28.0B33.8B45.4B
Property, plant and equipment22.3B23.1B24.4B28.6B29.1B33.2B30.2B29.9B29.1B
Goodwill10.3B9.77B9.53B9.45B8.91B9.04B8.75B8.21B8.41B7.37B
Total assets86.2B81.3B76.5B76.8B82.4B77.7B81.8B78.3B81.6B89.7B
Accounts payable5.63B5.92B7.66B8.67B9.21B6.96B8.95B8.40B6.02B5.34B
Current liabilities16.2B20.4B27.9B34.4B32.1B31.2B35.0B28.5B26.9B19.8B
Long-term debt15.2B12.1B8.91B2.24B3.55B5.03B12.4B18.9B21.7B31.9B
Total debt22.3B20.2B23.6B21.8B22.0B26.7B35.8B33.7B37.5B41.5B
Total liabilities33.3B34.8B39.9B40.2B40.4B40.1B51.2B48.3B49.6B52.5B
Shareholders' equity49.4B43.5B33.6B33.5B38.5B33.8B26.7B26.7B28.5B33.4B
Shares outstanding162.6M156.9M144.3M144.1M120.6M120.1M110.7M110.7M110.6M110.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations2.00B-220.0M2.19B1.53B4.13B-2.87B6.49B1.83B684.4M-2.69B
Capital spending-1.36B-940.0M-2.16B-2.09B-2.12B-1.66B-1.72B-2.75B-3.07B-4.11B
Free cash flow640.0M-1.16B30.0M-560.0M2.01B-4.53B4.77B-915.5M-2.39B-6.80B
Cash from investing-2.75B-7.83B-1.37B-1.25B-2.01B14.7B-1.56B945.7M6.30B-6.86B
Cash from financing1.41B4.09B3.34B-3.15B-710.0M-11.7B-6.80B-7.76B-7.69B12.5B
Dividends paid-20.0M-5.30M-5.30M-200.0K-1.00M-1.38B
Share buybacks9.83B4.68B07.48B-3.54B300.0K-2.71B500.0K200.0K
Change in cash960.0M-3.93B4.15B-2.80B1.38B129.1M-1.78B-5.00B-664.0M3.01B

Open Financials

Filings

FilingDateTypeFiled with
Wockhardt Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.".Nov 2, 2026ResultsNSE India
Wockhardt Limited Press Release Aug 10 2026Aug 10, 2026Other filingsNSE India
Press Release May 30 2026May 30, 2026Other filingsNSE India
Press Release May 28 2026May 27, 2026Operations updateNSE India
Press Release May 04 2026May 4, 2026ResultsNSE India
Wockhardt Limited Press Release Mar 30 2026Mar 29, 2026Other filingsNSE India
Press Release Feb 10 2026Feb 10, 2026Other filingsNSE India
Wockhardt Limited Press Release Jan 27 2026Jan 26, 2026Other filingsNSE India
Wockhardt Limited Press Release Jan 07 2026Jan 6, 2026Other filingsNSE India
Press Release Dec 31 2025Dec 31, 2025Other filingsNSE India
All 58 filings
FilingDateTypeFiled with
Press Release Dec 01 2025Dec 1, 2025Other filingsNSE India
Press Release Nov 03 2025Nov 3, 2025ResultsNSE India
Wockhardt Limited Press Release Oct 01 2025Sep 30, 2025Operations updateNSE India
Press Release Sep 25 2025Sep 25, 2025Other filingsNSE India
Press Release Aug 08 2025Aug 8, 2025ResultsNSE India
Wockhardt Limited Press Release Jul 28 2025Jul 27, 2025Other filingsNSE India
Press Release Jul 11 2025Jul 11, 2025Operations updateNSE India
Press Release May 29 2025May 29, 2025Other filingsNSE India
Wockhardt Limited Press Release Apr 01 2025Mar 31, 2025Operations updateNSE India
Press Release Feb 07 2025Feb 7, 2025Other filingsNSE India
Wockhardt Limited Press Release Jan 31 2025Jan 30, 2025Operations updateNSE India
Wockhardt Limited Press Release Jan 13 2025Jan 12, 2025Operations updateNSE India
Press Release Jan 02 2025Jan 2, 2025Operations updateNSE India
Wockhardt Limited Press Release Dec 16 2024Dec 15, 2024Other filingsNSE India
Press Release Nov 13 2024Nov 13, 2024ResultsNSE India
Wockhardt Limited Press Release Oct 16 2024Oct 15, 2024Operations updateNSE India
Press Release Oct 11 2024Oct 11, 2024Operations updateNSE India
Press Release Oct 07 2024Oct 7, 2024Operations updateNSE India
Wockhardt Limited Press Release Sep 19 2024Sep 18, 2024Operations updateNSE India
Wockhardt Limited Press Release Sep 16 2024Sep 15, 2024Other filingsNSE India
Press Release Aug 09 2024Aug 9, 2024ResultsNSE India
Press Release Jun 28 2024Jun 28, 2024Operations updateNSE India
Press Release May 28 2024May 28, 2024Other filingsNSE India
Press Release Mar 11 2024Mar 11, 2024Other filingsNSE India
Press Release Feb 14 2024Feb 14, 2024Other filingsNSE India
Press Release Dec 11 2023Dec 11, 2023Operations updateNSE India
Press Release Nov 14 2023Nov 14, 2023ResultsNSE India
Press Release Aug 14 2023Aug 14, 2023ResultsNSE India
Press Release May 26 2023May 26, 2023ResultsNSE India
Press Release Aug 16 2022Aug 16, 2022Other filingsNSE India
Press Release Mar 20 2022Mar 20, 2022Operations updateNSE India
Press Release Mar 16 2022Mar 16, 2022Other filingsNSE India
Press Release Feb 08 2022Feb 8, 2022Other filingsNSE India
Press Release Jan 27 2022Jan 27, 2022Other filingsNSE India
Press Release Nov 08 2021Nov 8, 2021Other filingsNSE India
Press Release Aug 26 2021Aug 26, 2021Other filingsNSE India
Press Release Aug 13 2021Aug 13, 2021Other filingsNSE India
Press Release Jul 27 2021Jul 27, 2021Other filingsNSE India
Press Release Jul 22 2021Jul 22, 2021Other filingsNSE India
Press Release Jul 05 2021Jul 5, 2021Other filingsNSE India
Press Release May 27 2021May 27, 2021ResultsNSE India
Press Release Feb 10 2021Feb 10, 2021Other filingsNSE India
Press Release Jan 29 2021Jan 29, 2021ResultsNSE India
Press Release Dec 01 2020Dec 1, 2020Other filingsNSE India
Press Release Nov 02 2020Nov 2, 2020ResultsNSE India
Press Release Aug 31 2020Aug 31, 2020Management or board changeNSE India
Press Release Aug 29 2020Aug 29, 2020Other filingsNSE India
Press Release Aug 03 2020Aug 3, 2020Other filingsNSE India

Open Filings

Cap table

Built by 6ix from Wockhardt Limited’s releases

Common shares
162,492,169
Fully diluted
162,492,169

Fully diluted

LineShares
Common shares162,492,169

Share count over time

CountShares
Nov 22, 2026162,492,169

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Emerging Markets Stock Index Fund1.18MUS$24.3MJul 31, 2026
Vanguard Total International Stock Index Fund1.17MUS$24MJul 31, 2026
iShares Core MSCI Emerging Markets ETF866KUS$18.5MMay 31, 2026
Emerging Markets Core Equity 2 Portfolio363KUS$7.46MJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund303KUS$6.23MJul 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF291KUS$5.96MJun 30, 2026
iShares Core MSCI Total International Stock ETF144KUS$2.96MJul 31, 2026
iShares MSCI India Small-Cap ETF131KUS$2.8MMay 31, 2026
Avantis Emerging Markets Equity ETF121KUS$2.59MMay 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF87,568US$1.8MJul 31, 2026
All 31 holders
HolderSharesValueAs of
Vanguard Total World Stock Index Fund62,644US$1.29MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account54,308US$1.11MJun 30, 2026
Dimensional Emerging Core Equity Market ETF51,525US$1.06MJul 31, 2026
Fidelity Total International Index Fund44,953US$924KJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio21,369US$438KJun 30, 2026
Avantis Emerging Markets Value ETF21,069US$450KMay 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF20,023US$411KJun 30, 2026
iShares MSCI Emerging Markets Small-Cap ETF19,430US$415KMay 31, 2026
Vanguard ESG International Stock ETF17,997US$385KMay 31, 2026
Emerging Markets ex China Core Equity Portfolio15,559US$319KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF7,489US$154KJul 31, 2026
World ex U.S. Core Equity Portfolio2,792US$57,296Jul 31, 2026
SA Emerging Markets Value Fund2,598US$53,520Jun 30, 2026
Avantis Emerging Markets Small Cap Equity ETF2,285US$48,848May 31, 2026
World ex U.S. Targeted Value Portfolio1,543US$31,665Jul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio1,522US$31,234Jul 31, 2026
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund1,511US$31,034Jul 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF1,313US$26,967Jul 31, 2026
Avantis Emerging Markets ex-China Equity ETF1,196US$25,568May 31, 2026
Emerging Markets Targeted Value Portfolio1,072US$21,999Jul 31, 2026
Xtrackers Nifty 500 India ETF176US$3,763May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ajay SahniManaging Director – Wockhardt Bio AG; Managing Director – Pinewood Healthcare · Since at least Nov 4, 2026
AKHILESH GUPTAIndependent Director · Since at least Nov 6, 2026
Amb. AHMAD JAVEDIndependent Director · Since at least Nov 6, 2026
Amelia FernandesIndependent Director · Since at least Nov 6, 2026
Annapurna DasPresident – India Business & NCE Emerging Markets · Since at least Nov 6, 2026
Debolina PartapSr. Vice President – Legal · Since at least Nov 6, 2026
Deepak R. MadnaniChief Financial Officer – Finance · Since at least Nov 6, 2026
Gopalakrishnan VenkatesanPresident & VP Business Development – Morton Grove Pharmaceuticals & Wockhardt USA LLC · Since at least Nov 6, 2026
HABIL KHORAKIWALAFounder Chairman · Since at least Jun 1, 2026
HUZAIFA KHORAKIWALAExecutive Director · Since at least Nov 6, 2026
All 18 people
PersonSeat
Mahesh V. PatelChief Scientific Officer – New Drug Discovery · Since at least Nov 6, 2026
MURTAZA KHORAKIWALAManaging Director · Since at least Nov 6, 2026
Om NarayanSenior Vice President – Biotech R&D · Since at least Nov 6, 2026
Om Prakash BhattIndependent Director · Since at least Nov 6, 2026
Ravi LimayeManaging Director – Wockhardt UK · Since at least Nov 6, 2026
Sumit GargChief Digital & Information Officer (CDIO) · Since at least Nov 6, 2026
VINESH KUMAR JAIRATHIndependent Director · Since at least Nov 6, 2026
ZAHABIYA KHORAKIWALANon-Executive Director · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Wockhardt Limited.